Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients

Evidence suggests lower nadir testosterone levels during the first year of androgen deprivation therapy improve advanced prostate cancer clinical outcomes. We evaluated pivotal trials for subcutaneously administered leuprolide acetate (1-, 3-, 4-, and 6-month doses) to determine nadir testosterone l...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Rev Urol
Päätekijät: Pieczonka, Christopher M., Twardowski, Przemyslaw, Renzulli, Joseph, Hafron, Jason, Boldt-Houle, Deborah M., Atkinson, Stuart, Eggener, Scott
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MedReviews, LLC 2018
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168320/
https://ncbi.nlm.nih.gov/pubmed/30288142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3909/riu0798
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia